| Primary |
| Hepatitis C |
46.9% |
| Chronic Hepatitis C |
24.6% |
| Product Used For Unknown Indication |
7.9% |
| Hiv Infection |
6.3% |
| Hepatic Cirrhosis |
2.4% |
| Hypertension |
2.1% |
| Anaemia |
1.5% |
| Depression |
1.5% |
| Prophylaxis |
1.0% |
| Diabetes Mellitus |
0.9% |
| Pain |
0.7% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Pruritus |
0.5% |
| Influenza Like Illness |
0.5% |
| Oedema Peripheral |
0.5% |
| Thrombocytopenia |
0.5% |
| Affective Disorder |
0.4% |
| Asthma |
0.4% |
| Dry Skin |
0.4% |
| Hepatitis C Virus Test Positive |
0.4% |
|
| Anaemia |
20.6% |
| White Blood Cell Count Decreased |
7.9% |
| Neutropenia |
7.6% |
| Rash |
7.6% |
| Thrombocytopenia |
7.6% |
| Vomiting |
7.2% |
| Fatigue |
4.7% |
| Syncope |
4.0% |
| Pancytopenia |
3.6% |
| General Physical Health Deterioration |
3.2% |
| Leukopenia |
3.2% |
| Pyrexia |
3.2% |
| Atrial Fibrillation |
2.9% |
| Weight Decreased |
2.9% |
| Sepsis |
2.5% |
| Suicidal Ideation |
2.5% |
| Depression |
2.2% |
| Dyspnoea |
2.2% |
| Nausea |
2.2% |
| Pneumonia |
2.2% |
|
| Secondary |
| Hepatitis C |
49.6% |
| Chronic Hepatitis C |
27.0% |
| Hiv Infection |
3.9% |
| Product Used For Unknown Indication |
3.7% |
| Hepatic Cirrhosis |
2.5% |
| Hypertension |
1.9% |
| Routine Health Maintenance |
1.8% |
| Headache |
1.2% |
| Pain |
1.1% |
| Depression |
1.0% |
| Haemoglobin Decreased |
0.9% |
| Oedema |
0.8% |
| Insomnia |
0.8% |
| Oesophageal Disorder |
0.8% |
| Drug Withdrawal Maintenance Therapy |
0.6% |
| Prophylaxis |
0.6% |
| Anaemia |
0.5% |
| Infection |
0.5% |
| Gastritis |
0.5% |
| Encephalopathy |
0.4% |
|
| Anaemia |
18.3% |
| White Blood Cell Count Decreased |
14.6% |
| Atrioventricular Block First Degree |
6.4% |
| Neutropenia |
5.9% |
| Pancytopenia |
5.9% |
| Suicidal Ideation |
5.9% |
| Weight Decreased |
5.5% |
| Thrombocytopenia |
5.0% |
| Pyrexia |
4.1% |
| Deep Vein Thrombosis |
3.2% |
| Syncope |
3.2% |
| Vomiting |
3.2% |
| Lymphadenopathy |
2.7% |
| Pneumonia |
2.7% |
| Metabolic Encephalopathy |
2.3% |
| Rhabdomyolysis |
2.3% |
| Sepsis |
2.3% |
| Toxic Encephalopathy |
2.3% |
| Urinary Tract Infection |
2.3% |
| Chills |
1.8% |
|
| Concomitant |
| Hepatitis C |
50.0% |
| Liver Disorder |
8.3% |
| Chronic Hepatitis C |
6.9% |
| Anxiety |
5.6% |
| Depression |
5.6% |
| Pain |
3.5% |
| Anaemia |
2.8% |
| Asthma |
2.8% |
| Immunosuppression |
2.8% |
| Smoking Cessation Therapy |
2.8% |
| Chronic Hepatitis |
2.1% |
| Immunisation |
1.4% |
| Polyneuropathy |
1.4% |
| Decreased Appetite |
0.7% |
| Gastritis |
0.7% |
| Haemoglobin Decreased |
0.7% |
| Insomnia |
0.7% |
| Narcolepsy |
0.7% |
| Varices Oesophageal |
0.7% |
|
| Platelet Count Decreased |
11.5% |
| Anxiety |
7.7% |
| Haemoglobin Decreased |
7.7% |
| Intentional Overdose |
7.7% |
| Viral Load Increased |
7.7% |
| Anaemia |
3.8% |
| Ascites |
3.8% |
| Aspartate Aminotransferase Increased |
3.8% |
| Asthenia |
3.8% |
| Convulsion |
3.8% |
| Cryoglobulinaemia |
3.8% |
| Death |
3.8% |
| Decreased Appetite |
3.8% |
| Diarrhoea |
3.8% |
| Drug Dose Omission |
3.8% |
| Energy Increased |
3.8% |
| Eye Irritation |
3.8% |
| Incorrect Product Storage |
3.8% |
| Medication Error |
3.8% |
| Metabolic Encephalopathy |
3.8% |
|
| Interacting |
| Hepatitis C |
31.9% |
| Product Used For Unknown Indication |
11.1% |
| Hepatitis Cholestatic |
6.9% |
| Pain |
5.6% |
| Hepatitis C Antibody Positive |
4.2% |
| Hepatitis C Virus Test Positive |
4.2% |
| Immunosuppressant Drug Therapy |
4.2% |
| Affective Disorder |
2.8% |
| Benign Prostatic Hyperplasia |
2.8% |
| Cough |
2.8% |
| Diarrhoea |
2.8% |
| Hiv Infection |
2.8% |
| Hypogonadism |
2.8% |
| Immunosuppression |
2.8% |
| Liver Transplant |
2.8% |
| Muscle Spasms |
2.8% |
| Nausea |
2.8% |
| Essential Hypertension |
1.4% |
| Shunt Thrombosis |
1.4% |
| Vomiting |
1.4% |
|
| Neutropenia |
30.0% |
| Drug Interaction |
20.0% |
| Priapism |
20.0% |
| Hepatic Cirrhosis |
10.0% |
| Rash |
10.0% |
| Unevaluable Event |
10.0% |
|
